PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Cash-to-Debt : 216.73 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is PT Darya-Varia Laboratoria Tbk Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. PT Darya-Varia Laboratoria Tbk's cash to debt ratio for the quarter that ended in Mar. 2024 was 216.73.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, PT Darya-Varia Laboratoria Tbk could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Cash-to-Debt or its related term are showing as below:

ISX:DVLA' s Cash-to-Debt Range Over the Past 10 Years
Min: 14.44 Med: No Debt Max: No Debt
Current: 216.73

During the past 13 years, PT Darya-Varia Laboratoria Tbk's highest Cash to Debt Ratio was No Debt. The lowest was 14.44. And the median was No Debt.

ISX:DVLA's Cash-to-Debt is ranked better than
90.12% of 1002 companies
in the Drug Manufacturers industry
Industry Median: 0.96 vs ISX:DVLA: 216.73

PT Darya-Varia Laboratoria Tbk Cash-to-Debt Historical Data

The historical data trend for PT Darya-Varia Laboratoria Tbk's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

PT Darya-Varia Laboratoria Tbk Cash-to-Debt Chart

PT Darya-Varia Laboratoria Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

281.12

25.38

189.13

162.83

PT Darya-Varia Laboratoria Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															172.28	188.19	215.92	162.83	216.73

Competitive Comparison of PT Darya-Varia Laboratoria Tbk's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Darya-Varia Laboratoria Tbk's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Cash-to-Debt falls into.

PT Darya-Varia Laboratoria Tbk Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

PT Darya-Varia Laboratoria Tbk's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	240043.152	/	(430.44	+	1043.765)
	=	162.83

PT Darya-Varia Laboratoria Tbk's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	296524.592	/	(434.778	+	933.431)
	=	216.72

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

PT Darya-Varia Laboratoria Tbk Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of PT Darya-Varia Laboratoria Tbk's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Darya-Varia Laboratoria Tbk (ISX:DVLA) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430

Website

https://www.darya-varia.com

PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, medical and dental equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics; wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory equipment, cosmetic; wholesale trade in pharmaceuticals; laboratory testing services, health support service activities, research and development, periodic inspection services, and many more activities.

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Headlines

No Headlines